<DOC>
	<DOC>NCT01181518</DOC>
	<brief_summary>The clinical outcome of tamoxifen treatment in breast cancer patients may be influenced by the activity of cytochrome P450 enzymes involving in tamoxifen biotransformation.</brief_summary>
	<brief_title>Tamoxifen Pharmacogenetics in Asian Breast Cancer Women</brief_title>
	<detailed_description>The investigators investigated the prognostic and/or predictive value of genetic polymorphisms of enzymes involved in tamoxifen metabolism for the treatment outcome among Asian breast cancer patients.</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Poisoning</mesh_term>
	<mesh_term>Tamoxifen</mesh_term>
	<criteria>incident breast cancer patients who underwent surgery previous cancer history before breast cancer diagnosis</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Tamoxifen</keyword>
	<keyword>Pharmacogenomics</keyword>
	<keyword>Breast cancer</keyword>
</DOC>